EMVision Medical
Developing portable electromagnetic microwave imaging solutions.
Launch date
Employees
Market cap
CAD161m
Enterprise valuation
CAD147m (Public information from Sep 2024)
Share price
AUD2.05 EMV.AX
Brisbane Queensland (HQ)
Financials
Estimates*
| AUD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.0m | 2.0m | 2.0m | 4.0m | 7.0m | 11.6m | 10.1m |
| % growth | 103 % | 100 % | - | 100 % | 75 % | 65 % | (13 %) |
| EBITDA | - | (3.5m) | (8.3m) | (5.8m) | (3.5m) | - | - |
| % EBITDA margin | - | (174 %) | (414 %) | (146 %) | (50 %) | - | - |
| Profit | - | (3.5m) | (8.4m) | (6.1m) | (3.9m) | - | - |
| % profit margin | - | (174 %) | (420 %) | (153 %) | (55 %) | - | - |
| EV / revenue | 16.6x | 40.0x | 103.7x | 27.6x | 12.0x | 14.6x | - |
| EV / EBITDA | - | -23.0x | -25.1x | -18.9x | -24.1x | - | - |
| R&D budget | - | 2.9m | 2.7m | 2.3m | 2.0m | - | - |
| R&D % of revenue | - | 147 % | 135 % | 58 % | 29 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | AUD5.0m | Grant |
* | AUD2.5m | Grant | |
* | AUD1.8m | Grant | |
* | AUD15.3m | Post IPO Equity | |
| Total Funding | CAD8.2m | ||
Related Content
Recent News about EMVision Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.